API | oteseconazole

oteseconazole (Vivjoa) Report issue

Small molecule Approved ^FDA Fast Track ^FDA Priority Review ^FDA

AACT DrugBank PubChem

Active Ingredient History

NOW

Chemistry

SMILES: O[C@@](Cn1cnnn1)(c1ccc(F)cc1F)C(F)(F)c1ccc(-c2ccc(OCC(F)(F)F)cc2)cn1
InChIKey: IDUYJRXRDSPPRC-NRFANRHFSA-N
Mol. Mass: 527.4
ALogP: 4.63 Partition coefficient
ChEMBL Molecule:
oteseconazole

More Chemistry

Pharmacology

Mechanisms of Action:
- 14-alpha sterol demethylase (Neosartorya fumigata) ^UniProt
- Lanosterol 14-alpha demethylase (Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)) ^UniProt
Multi-specific: Missing data
Black Box: No
Availability: Prescription Only
Delivery Methods: Oral
Pro Drug: No

oteseconazole | vt-1161

Organizations (3)

Research & Development (3)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (1)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (3)

Approved Indications (1)

Candidiasis, Vulvovaginal

Experimental Indications - Clinical Trial Phases 1-4 (3)

Candidiasis, Vulvovaginal (Phase 3)

Onychomycosis (Phase 2)

Tinea Pedis (Phase 2)

Overview

Highest Phase: Phase 3
# of Trials: 9
# of Trial Organizations: 3

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue